Overview

Study of CT001 in Healthy Volunteers

Status:
Completed

Trial end date:
2021-06-02

Target enrollment:

Participant gender:

Summary

A phase 1, three arms, cross over comparison study to evaluate bioavailability, pharmacokinetics and safety of intra nasal CT001 in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Cessatech A/S

Collaborators:

Dantrials Aps
Smerud Medical Research International AS

Treatments:

Ketamine
Sufentanil